The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Abstract Text:

OBJECTIVES: The effect of anti-tumour necrosis factor (TNF) therapy on the antibody responses to vaccines is the subject of ongoing debate. Therefore, we investigated the effect of the three currently available anti-TNF agents on influenza vaccination outcomes in a patient population with long-standing disease. METHODS: In a prospective cohort study, we assessed the antibody response upon influenza vaccination in 112 patients with long-standing autoimmune disease treated with immunosuppressive medication either with anti-TNF (etanercept, adalimumab or infliximab; n = 64) or without anti-TNF (n = 48) and a control group of 18 healthy individuals. Antibody responses were determined by haemagglutination inhibition assay, before and 4 weeks after vaccination. RESULTS: The proportion of individuals with a protective titre (>or=40) after vaccination was large (80-94%) and did not significantly differ between the three groups. Post-vaccination geometric mean antibody titres against influenza (A/H3N2 and B) were significantly lower in the 64 patients treated with anti-TNF compared with the 48 patients not receiving anti-TNF, and the healthy controls. CONCLUSIONS: The antibody response to influenza vaccination in patients treated with anti-TNF is only modestly impaired. The proportion of patients that achieves a protective titre is not significantly diminished by the use of TNF blocking therapies.

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Annals of the rheumatic diseases

VOLUME: 67

Page Numbers: 713-6

Journal Abbreviation: Ann. Rheum. Dis.

ISSN: 1468-2060

DAY: 26

MONTH: 10

YEAR: 2007

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372355

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.

AFFILIATION: Department of Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, The Netherlands. L.B.S.Gelinck@LUMC.nl

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann Rheum Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination Related Publications

• Brazilian Vaccinia virus strains are genetically divergent and differ from the Lister vaccine strain.
• Brazilian Vaccinia virus strains show genetic polymorphism at the ati gene.
• Climbing the steps of viral atomic force microscopy: visualization of Dengue virus particles.
• Drug interactions with smoking.
• Feline infectious peritonitis (FIP) virus. IV. Propagation in suckling rat and hamster brain.
• Hybrid multi-channel/cue coding/decoding of audio signals.
• Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
• Interferons and scleroderma-A new clue to understanding the pathogenesis of scleroderma?
• Osteosarcoma of the femur with skip, lymph node, and lung metastases.
• Spinal chordoma: radiologic features in 14 cases.
• Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine.
• The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.
• Urinary excretion of strawberry anthocyanins is dose dependent for physiological oral doses of fresh fruit.
• Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains.
• [Not Available.]
• [Standard patch testing and nickel allergy in Stavanger, Norway.]
• [The implementation of Individual Placement and Support in the Netherlands]